CAN HIGH DOSE OF VITAMIN C TREAT CANCER?

Recent clinical trials have explored the use of high-dose intravenous (IV) vitamin C as a complementary therapy in cancer treatment. While findings are preliminary, some studies suggest potential benefits when combining high-dose IV vitamin C with standard cancer treatments.

Key Findings:

·       Pancreatic Cancer: A randomized phase 2 clinical trial reported that adding high-dose IV vitamin C to chemotherapy doubled the overall survival of patients with advanced pancreatic cancer from eight months to 16 months. citeturn0search1

·       Bladder Cancer: Researchers have initiated a Phase II clinical trial to assess the combination of high-dose IV vitamin C with chemotherapies gemcitabine and carboplatin in patients who cannot receive standard cisplatin-based chemotherapy. citeturn0search4

·       General Cancer Research: Early-phase clinical trials have confirmed the safety of high-dose IV vitamin C and indicated its efficacy in eradicating tumor cells across various cancer types. citeturn0search5

Considerations:

Despite these promising results, the efficacy of high-dose vitamin C therapy remains to be determined, as many studies were not designed as large-scale, randomized controlled trials. citeturn0search0

It's important to note that while these studies are encouraging, high-dose vitamin C therapy is still under investigation. Patients should consult with their healthcare providers before considering such treatments.